收藏切换
Rhamnose-analogues mediated liposomal drug delivery system for pancreatic cancer target therapy
收藏切换
PDF
Fei-yan GAO1, Xin-long LIU1, Shan PENG1, Yan ZHANG2, *, Chong LI1, *
Acta Pharmaceutica Sinica | 2024, 59(4) : 1067 - 1078
Less
收藏切换
Acta Pharmaceutica Sinica | 2024, 59(4): 1067-1078
Original Articles
Rhamnose-analogues mediated liposomal drug delivery system for pancreatic cancer target therapy
Full
Fei-yan GAO1, Xin-long LIU1, Shan PENG1, Yan ZHANG2, *, Chong LI1, *
Affiliations
  • 1. College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China
  • 2. School of Pharmacy, Chongqing University, Chongqing 401331, China
Published: 2024-04-12 doi: 10.16438/j.0513-4870.2023-1344
Outline
收藏切换

In this study, we have firstly investigated the feasibility of rhamnolipids as targeting ligands to develop drug delivery systems for active targeting of pancreatic cancer. Rhamnolipid-modified liposomes (RhaL-Lip) were prepared by a thin film hydration method, and were evaluated preliminarily for RhaL-Lip physicochemical properties, in vitro release characteristics, ex/in vivo targeting, and in vitro pharmacodynamics. RhaL-Lip exhibited excellent targeting ability of human pancreatic cancer (BxPC-3) cells and enhanced anti-tumor effects. On this basis, the natural structural analogue of rhamnolipid, Polyphyllin Ⅶ (PPVⅡ), as the targeting material and active ingredient, we explored the targeting and anti-tumor activity of Polyphyllin Ⅶ modified liposomes (PPVⅡ-Lip). The results showed that PPVⅡ-Lip has a homogeneous particle size and has a more robust targeting ability for solid tumor in vivo, which can achieve more enrichment at the tumor site. Compared with gemcitabine, the first-line chemotherapy drug for pancreatic cancer, PPVⅡ-Lip showed a stronger inhibitory effect. In conclusion, this targeted drug delivery strategy is expected to provide beneficial ideas for drug delivery studies in targeted therapy for pancreatic cancer. Animal experiments were conducted with approval from the Animal Ethics Committee of southwest university (approval number: IACUC-20210130-2).

rhamnolipid  /  polyphyllin Ⅶ  /  targeted drug delivery system  /  pancreatic cancer
Fei-yan GAO, Xin-long LIU, Shan PENG, Yan ZHANG, Chong LI. Rhamnose-analogues mediated liposomal drug delivery system for pancreatic cancer target therapy[J]. Acta Pharmaceutica Sinica, 2024 , 59 (4) : 1067 -1078 . DOI: 10.16438/j.0513-4870.2023-1344
Year 2024 volume 59 Issue 4
PDF
998
876
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2023-1344
  • Receive Date:2023-11-28
  • Online Date:2025-11-28
  • Published:2024-04-12
Article Data
Affiliations
History
  • Received:2023-11-28
  • Revised:2024-03-16
Funding
Affiliations
    1. College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China
    2. School of Pharmacy, Chongqing University, Chongqing 401331, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2023-1344
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT